DARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion push

Go back to DARZALEX royalties drive Genmab’s Q1 revenue higher amid expansion push
(NASDAQ: GMAB) Delayed: 25.94 +0.33 (1.29%)
Previous Close $25.61    52 Week High
Open $25.92    52 Week Low
Day High $26.19    P/E N/A 
Day Low $25.85    EPS
Volume 1,261,307